Current Topics in Pharmacology 2010-2011 Schedule
Meets: Thursdays 12:30 PM
Room: T-747 HSB
| October | 14 | Richard Gardner | SNAREing a role for alpha-synuclein in neurodegenerative disease | |
| 21 | Bret Samelson | Gamma-secretase activating protein is a therapeutic for Alzheimer's disease | ||
| 28 | Rebecca Kow | Brain Cholesterol is Decreased in Models of Huntington's Disease | ||
| November | 4 | Jessica Hill | Presenilins and neurotransmitter release: Could presynaptic dysfunction be an early pathogenic event leading to AD? | |
| December | 2 | Patrick Nygren | Dendritic functions of tau in Alzheimer's disease. | |
| January | 13 | Sonya Trejo | How can mu do this to me? Mu-Opioid receptor inhibition of Wnt secretion. | |
| 20 | Jen Whiting | AMPK regulates microtubule dynamics via CLIP-170 | ||
| 27 | Allison Cherry | Lipid Accumulation Inhibits Dendritic Cell Function in Cancer | ||
| February | 3 | Mario Rosasco | Talking Trash to Get Ahead: Switching Ubiquitination to Promote Axonal Growth | |
| 10 | Jeff Estella | An AMPK Agonist a Day Keeps Your Trainer Away | ||
| 17 | Kole Meeker | Make up your mind adenosine: neuroprotective or cytotoxic after brain injury? | ||
| 24 | Ben Reed | Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells | ||
| March | 3 | Edith Wang | Shattering Chromosomes in Cancer: Fact or Fiction? | |
| April | 7 | Wendy Yang | Dopamine? More like Mope-amine: Mesolimbic Dopamine Neurons Mediate Susceptibility to Stress | |
| 14 | Nick Strand | Hungry, Hungry, Hippo: Organ Size Modulation and Tumor Suppression | ||
| 21 | Rebecca Minich | Serpin for a reason: Collagen chaperone mutation causes severe Osteogenesis Imperfecta | ||
| 28 | Jennifer Deem | iPSCs have issues, too | ||
| May | 5 | Amanda Chung | Biopolymers and Bacteria and Nanoparticles, oh my! New Nanostructures Degrade Bacterial Membranes | |
| 12 | Jamie Levin | Understanding Chemotherapy Resistances | ||
| 19 | Lauren Burgeno | A role for Protein Kinase M? in the the Enhancement of Consolidated Long-Term Memory | ||
| 26 | Jim Ruble | What the heck is a rhomboid? Inhibitor development using HTS and SAR to study rhomboid intramembrane proteases. | ||